Rain Enhancement Technologies Holdco, Inc. (RAIN)
NASDAQ: RAIN · Real-Time Price · USD
4.060
-0.160 (-3.79%)
Jan 22, 2025, 1:39 PM EST - Market open
Company Description
Rain Enhancement Technologies Holdco, Inc. develops, manufactures, and commercializes ionization rainfall generation technology.
The company is based in Naples, Florida. Rain Enhancement Technologies Holdco, Inc. operates as a subsidiary of Rainwater, LLC.
Rain Enhancement Technologies Holdco, Inc.
| Country | United States |
| Founded | 2022 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 63 |
| CEO | Avanish Vellanki M.B.A. |
Contact Details
Address: 1659 Chinaberry Ct. Naples, Florida 34105 United States | |
| Phone | (508) 361-6699 |
| Website | rainwatertech.com |
Stock Details
| Ticker Symbol | RAIN |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0002028293 |
| ISIN Number | US75080J1034 |
| Employer ID | 99-3527155 |
| SIC Code | 3590 |
Key Executives
| Name | Position |
|---|---|
| Avanish Vellanki M.B.A. | Co-Founder, Chief Executive Officer and Chairman |
| Dr. Robert C. Doebele M.D., Ph.D. | Co-Founder, Chairman of Scientific Advisory Board, President and CSO and Chief Medical Officer |
| Josephine Bruce | Principal Financial and Accounting officer |
| Theresa O'Connell M.S. | Director of Corporate Development and Operations |
| Erik Atkisson | General Counsel and Chief Compliance Officer |
| Charmi Turner | Vice President of People and Culture |
| Vijaya Tirunagaru Ph.D. | Senior Vice President and Head of Research |
| Dr. Nora Ku M.D. | MD and Vice President of Clinical Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 7, 2025 | 8-K | Current Report |
| Jan 3, 2025 | SCHEDULE 13D | Filing |
| Dec 31, 2024 | 8-K | Current Report |
| Dec 31, 2024 | CERT | Certification by an exchange approving securities for listing |
| Dec 30, 2024 | 425 | Filing |
| Dec 30, 2024 | 425 | Filing |
| Dec 30, 2024 | 425 | Filing |
| Dec 30, 2024 | 8-K | Current Report |
| Dec 30, 2024 | 8-A12B | Registration of securities |
| Dec 18, 2024 | 424B3 | Prospectus |